120 related articles for article (PubMed ID: 26517485)
1. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies.
Bastug A; Kayaaslan B; Kazancioglu S; But A; Aslaner H; Akinci E; Yetkin MA; Kanyilmaz D; Eren SS; Bodur H
J Infect Dev Ctries; 2015 Oct; 9(10):1100-7. PubMed ID: 26517485
[TBL] [Abstract][Full Text] [Related]
2. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
[TBL] [Abstract][Full Text] [Related]
3. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
4. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
Trecarichi EM; Pagano L; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Caira M; Spadea A; Busca A; Vianelli N; Tumbarello M;
Clin Microbiol Infect; 2015 Apr; 21(4):337-43. PubMed ID: 25595706
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital.
Chaisathaphol T; Chayakulkeeree M
J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S35-45. PubMed ID: 24772579
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.
Zhao R; Ma J; Li P; Fang H; Sun S; Wu W; Chen J; Zhao H; Jin L; Shi Y; Sheng J
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1167-1174. PubMed ID: 30152255
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome.
Nemeth J; Ledergerber B; Preiswerk B; Nobile A; Karrer S; Ruef C; Kuster SP
J Hosp Infect; 2012 Dec; 82(4):254-9. PubMed ID: 23103249
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and prognostic determinants of bacteraemic biliary tract infection.
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; López J; Pitart C; Mensa J
J Antimicrob Chemother; 2012 Jun; 67(6):1508-13. PubMed ID: 22408140
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
[TBL] [Abstract][Full Text] [Related]
12. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M
PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499
[TBL] [Abstract][Full Text] [Related]
13. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
[TBL] [Abstract][Full Text] [Related]
15. Inadequate antibiotic therapy in solid organ transplant recipients is associated with a higher mortality rate.
Lupei MI; Mann HJ; Beilman GJ; Oancea C; Chipman JG
Surg Infect (Larchmt); 2010 Feb; 11(1):33-9. PubMed ID: 19785562
[TBL] [Abstract][Full Text] [Related]
16. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for infections caused by multidrug-resistant bacteria in patients with solid tumours.
Horasan ES; Ersoz G; Horoz M; Göksu M; Karacorlu S; Kaya A
Scand J Infect Dis; 2011 Feb; 43(2):107-11. PubMed ID: 21080767
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance to antimicrobials as a predominant factor influencing patient survival.
Giamarellos-Bourboulis EJ; Papadimitriou E; Galanakis N; Antonopoulou A; Tsaganos T; Kanellakopoulou K; Giamarellou H
Int J Antimicrob Agents; 2006 Jun; 27(6):476-81. PubMed ID: 16707252
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies.
Mert D; Ceken S; Iskender G; Iskender D; Merdin A; Duygu F; Ertek M; Altuntas F
J Infect Dev Ctries; 2019 Aug; 13(8):727-735. PubMed ID: 32069257
[TBL] [Abstract][Full Text] [Related]
20. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
